JP2019511465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511465A5 JP2019511465A5 JP2018542140A JP2018542140A JP2019511465A5 JP 2019511465 A5 JP2019511465 A5 JP 2019511465A5 JP 2018542140 A JP2018542140 A JP 2018542140A JP 2018542140 A JP2018542140 A JP 2018542140A JP 2019511465 A5 JP2019511465 A5 JP 2019511465A5
- Authority
- JP
- Japan
- Prior art keywords
- dry suspension
- weight
- suspension
- polymorph
- simethicone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021201709A JP7297858B2 (ja) | 2016-02-16 | 2021-12-13 | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662295710P | 2016-02-16 | 2016-02-16 | |
| US62/295,710 | 2016-02-16 | ||
| PCT/US2017/017915 WO2017142910A1 (en) | 2016-02-16 | 2017-02-15 | St-246 ( tecovirimat monohydrate) suspension formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021201709A Division JP7297858B2 (ja) | 2016-02-16 | 2021-12-13 | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511465A JP2019511465A (ja) | 2019-04-25 |
| JP2019511465A5 true JP2019511465A5 (enExample) | 2020-03-26 |
| JP7074677B2 JP7074677B2 (ja) | 2022-05-24 |
Family
ID=59625432
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542140A Active JP7074677B2 (ja) | 2016-02-16 | 2017-02-15 | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
| JP2021201709A Active JP7297858B2 (ja) | 2016-02-16 | 2021-12-13 | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021201709A Active JP7297858B2 (ja) | 2016-02-16 | 2021-12-13 | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11433051B2 (enExample) |
| EP (1) | EP3416637B1 (enExample) |
| JP (2) | JP7074677B2 (enExample) |
| CN (1) | CN108430469A (enExample) |
| AU (2) | AU2017221295B2 (enExample) |
| CA (1) | CA3013937A1 (enExample) |
| FI (1) | FI3416637T3 (enExample) |
| IL (1) | IL260229B2 (enExample) |
| WO (1) | WO2017142910A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7074677B2 (ja) * | 2016-02-16 | 2022-05-24 | シガ・テクノロジーズ・インコーポレーテッド | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
| EP4755373A1 (en) * | 2016-09-09 | 2026-06-10 | Azurity Pharmaceuticals, Inc. | Suspensions and diluents for metronidazole and baclofen |
| CN115141136B (zh) * | 2021-03-31 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | 特考韦瑞药的共晶及其制备方法 |
| CN114432241B (zh) * | 2021-12-21 | 2023-07-14 | 上海奥全生物医药科技有限公司 | 一种快速分散的助悬组合物、制备方法及其应用 |
| CN116625971B (zh) * | 2023-04-11 | 2026-04-17 | 北京达因高科儿童药物研究院有限公司 | 一种西甲硅油口溶膜中二甲硅油和二氧化硅含量的检测方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3043747A (en) * | 1958-10-22 | 1962-07-10 | Upjohn Co | Tablets coated with carboxymethylcellulose shellac composition |
| US4863737A (en) * | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
| ES2043766T3 (es) * | 1987-11-11 | 1994-01-01 | Pharmascience Lab | Una nueva composicion farmaceutica que comprende exifona y un polimero soluble en agua. |
| FR2705966B1 (fr) * | 1993-06-04 | 1995-08-25 | Dow Corning Sa | Compositions antimousse utiles notamment pour le traitement de troubles gastriques. |
| CN100571683C (zh) * | 2007-02-05 | 2009-12-23 | 深圳致君制药有限公司 | 干混悬剂及其制备方法 |
| PE20170944A1 (es) * | 2010-03-23 | 2017-07-13 | Siga Tech Inc | Formas polimorficas de st-246 y metodos de preparacion |
| CN102532901A (zh) | 2010-12-21 | 2012-07-04 | 重庆北碚现代应用药物研究所 | 一种西甲硅油的制备方法 |
| CN102406617B (zh) * | 2011-11-30 | 2013-08-28 | 中国人民解放军军事医学科学院生物工程研究所 | 一种替韦立马干混悬剂及其制备方法 |
| CN105055326B (zh) | 2015-07-17 | 2018-02-06 | 西南大学 | 西甲硅油干混悬剂及其制备方法 |
| JP7074677B2 (ja) * | 2016-02-16 | 2022-05-24 | シガ・テクノロジーズ・インコーポレーテッド | Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 |
-
2017
- 2017-02-15 JP JP2018542140A patent/JP7074677B2/ja active Active
- 2017-02-15 EP EP17753732.1A patent/EP3416637B1/en active Active
- 2017-02-15 WO PCT/US2017/017915 patent/WO2017142910A1/en not_active Ceased
- 2017-02-15 AU AU2017221295A patent/AU2017221295B2/en active Active
- 2017-02-15 CN CN201780005245.5A patent/CN108430469A/zh active Pending
- 2017-02-15 FI FIEP17753732.1T patent/FI3416637T3/fi active
- 2017-02-15 CA CA3013937A patent/CA3013937A1/en active Pending
- 2017-02-15 US US16/071,119 patent/US11433051B2/en active Active
-
2018
- 2018-06-24 IL IL260229A patent/IL260229B2/en unknown
-
2021
- 2021-12-13 JP JP2021201709A patent/JP7297858B2/ja active Active
-
2022
- 2022-07-14 US US17/864,909 patent/US11779566B2/en active Active
- 2022-08-18 AU AU2022218556A patent/AU2022218556B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4827915B2 (ja) | リファキシミンを含む胃抵抗性薬剤組成物 | |
| JP5128948B2 (ja) | 癌の治療のための新規な薬剤組成物 | |
| IL260229B2 (en) | Suspension formulations of st-246 (tecovirimate monohydrate) | |
| JP2014167026A5 (enExample) | ||
| KR101257919B1 (ko) | 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 경구용 고형 제제 및 이의 제조방법 | |
| AU6422898A (en) | Gastrointestinal mucosa-adherent pharmaceutical composition | |
| JP2009502835A (ja) | レベチラセタムを含む薬剤組成物及びその調製方法 | |
| JP2011503017A (ja) | ヒドロモルホン含有徐放性錠剤 | |
| JP2016518398A (ja) | 低用量医薬組成物 | |
| CN103118666A (zh) | 含有利福昔明的药物制剂、制备其的方法和治疗肠疾病的方法 | |
| WO2015199356A1 (en) | Composite formulation for oral administration comprising ezetimibe and rosuvastatin and a process for the preparation thereof | |
| JP2015500853A (ja) | 即時放出マルチユニットペレットシステム | |
| CN119421703A (zh) | 无定形固体分散体和包含所述无定形固体分散体的药物组合物 | |
| JP2020518611A (ja) | 水溶解度及びバイオアベイラビリティが改善された組成物 | |
| WO2014086857A1 (en) | Oral pharmaceutical composition comprising dabigatran etexilate | |
| WO2009122187A2 (en) | Pharmaceutical composition | |
| JP2007530565A (ja) | コーティング錠剤製剤およびその方法 | |
| WO2015019237A1 (en) | Pharmaceutical composition of vilazodone | |
| WO2015145157A1 (en) | Pharmaceutical composition comprising pazopanib | |
| WO2011080706A1 (en) | Enhanced solubility of ziprasidone | |
| WO2012176014A1 (en) | Imatinib mesylate oral pharmaceutical composition and process for preparation thereof | |
| EP3397285B1 (en) | Tablet formulations of montelukast sodium and rupatadine fumarate | |
| CA2984235C (en) | Rivastigmine-containing sustained-release pharmaceutical composition | |
| WO2007049291A1 (en) | Novel solid dosage forms of valsartan and rochlorothiazide | |
| JP2023127913A (ja) | ベンラファキシン塩酸塩含有顆粒 |